Anixa Biosciences Files 8-K
Ticker: ANIX · Form: 8-K · Filed: Dec 12, 2025 · CIK: 715446
| Field | Detail |
|---|---|
| Company | Anixa Biosciences Inc (ANIX) |
| Form Type | 8-K |
| Filed Date | Dec 12, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, regulatory
TL;DR
Anixa Biosciences filed an 8-K on Dec 11, 2025. Check for updates.
AI Summary
Anixa Biosciences, Inc. filed an 8-K on December 12, 2025, reporting an event on December 11, 2025. The filing is a Regulation FD Disclosure and includes Financial Statements and Exhibits. The company, formerly known as ITUS Corp and COPYTELE INC, is incorporated in Delaware and headquartered in San Jose, California.
Why It Matters
This 8-K filing indicates a regulatory disclosure event for Anixa Biosciences, Inc., which may contain important updates for investors regarding financial statements or other material information.
Risk Assessment
Risk Level: low — This filing is a standard 8-K disclosure and does not inherently indicate significant risk without further context on the specific items disclosed.
Key Numbers
- 20251211 — Event Date (Earliest event reported in the 8-K)
- 20251212 — Filing Date (Date the 8-K was filed with the SEC)
Key Players & Entities
- Anixa Biosciences, Inc. (company) — Registrant
- ITUS Corp (company) — Former company name
- COPYTELE INC (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- San Jose, CA (location) — Principal executive offices
FAQ
What specific event triggered this 8-K filing on December 11, 2025?
The filing indicates 'Regulation FD Disclosure' and 'Financial Statements and Exhibits' as item information, suggesting the event relates to these categories.
What was Anixa Biosciences, Inc.'s former name?
Anixa Biosciences, Inc. was formerly known as ITUS Corp and COPYTELE INC.
In which state is Anixa Biosciences, Inc. incorporated?
The company is incorporated in Delaware.
Where are Anixa Biosciences, Inc.'s principal executive offices located?
The principal executive offices are located at 3150 Almaden Expressway, Suite 250, San Jose, CA 95118.
What is the SIC code for Anixa Biosciences, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 703 words · 3 min read · ~2 pages · Grade level 11.9 · Accepted 2025-12-11 18:34:20
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share ANIX The NASDAQ Stock Mar
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 25KB
- ex99-2.htm (EX-99.2) — 1KB
- ex99-1_001.jpg (GRAPHIC) — 12KB
- ex99-2_001.jpg (GRAPHIC) — 8098KB
- 0001493152-25-027321.txt ( ) — 11397KB
- anix-20251211.xsd (EX-101.SCH) — 3KB
- anix-20251211_lab.xml (EX-101.LAB) — 33KB
- anix-20251211_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 11, 2025 ANIXA BIOSCIENCES, INC. By: /s/ Michael J. Catelani Name: Michael J. Catelani Title: President, Chief Operating Officer and Chief Financial Officer